Jeffrey S. Hatfield - 21 May 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Howard Horn, Attorney-in-Fact
Issuer symbol
VIR
Transactions as of
21 May 2021
Transactions value $
$0
Form type
4
Date filed
25 May 2021, 16:35
Next filing
25 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Award $0 +3.37K $0.00 3.37K 21 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +6.75K $0.00 6.75K 21 May 2021 Common Stock 6.75K $45.28 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.